Search research articles
Contact Us
Filters
Showing results (31-40 of 98) with videos related to
Page
of 10
Sort By:
Brain Research
|
April 9, 2001
Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage
F Fornai, G Battaglia, M Gesi, et al.
European Journal of Pharmacology
|
September 5, 1995
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice
F Fornai, L Bassi, M T Torracca, et al.
Archives Italiennes De Biologie
|
February 24, 2019
Step by step procedure for stereological counts of catecholamine neurons in the mouse brainstem
D Bucci, C L Busceti, F Biagioni, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 1997
Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions
F Fornai, M G Alessandrì, M T Torracca, et al.
Neuroscience and Biobehavioral Reviews
|
August 15, 2000
The role of the locus coeruleus in the development of Parkinson's disease
M Gesi, P Soldani, F S Giorgi, et al.
Journal of Neurochemistry
|
August 1, 1992
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates
A Zuddas, G Oberto, F Vaglini, et al.
Archives Italiennes De Biologie
|
June 23, 2021
Exosomes and alpha-synuclein within retina from autophagy to protein spreading in neurodegeneration
R Pinelli, M Bertelli, E Scaffidi, et al.
Journal of Neurochemistry
|
February 4, 1999
Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses
F Fornai, F S Giorgi, M G Alessandrì, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism
R Maggio, M Riva, F Vaglini, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|
June 1, 1996
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice
F Vaglini, F Fascetti, D Tedeschi, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 98) with videos related to
Sort By:
Page
of 10
Brain Research
|
April 9, 2001
Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage
F Fornai, G Battaglia, M Gesi, et al.
European Journal of Pharmacology
|
September 5, 1995
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice
F Fornai, L Bassi, M T Torracca, et al.
Archives Italiennes De Biologie
|
February 24, 2019
Step by step procedure for stereological counts of catecholamine neurons in the mouse brainstem
D Bucci, C L Busceti, F Biagioni, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 1997
Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions
F Fornai, M G Alessandrì, M T Torracca, et al.
Neuroscience and Biobehavioral Reviews
|
August 15, 2000
The role of the locus coeruleus in the development of Parkinson's disease
M Gesi, P Soldani, F S Giorgi, et al.
Journal of Neurochemistry
|
August 1, 1992
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates
A Zuddas, G Oberto, F Vaglini, et al.
Archives Italiennes De Biologie
|
June 23, 2021
Exosomes and alpha-synuclein within retina from autophagy to protein spreading in neurodegeneration
R Pinelli, M Bertelli, E Scaffidi, et al.
Journal of Neurochemistry
|
February 4, 1999
Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses
F Fornai, F S Giorgi, M G Alessandrì, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism
R Maggio, M Riva, F Vaglini, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|
June 1, 1996
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice
F Vaglini, F Fascetti, D Tedeschi, et al.
Page
of 10